Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-08-20
DOI
https://doi.org/10.3389/fimmu.2024.1430648
Citations
8
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma

Zhengming Jin, Depei Wu, Xiangping Zong, Jin Zhou et al.
8 citations
Frontiers in Immunology
Lymphoma Diagnosis and Treatment
3.40
article

Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma

Zhengming Jin, Depei Wu, Xiangping Zong, Jin Zhou, Zhen Yang
article en
8 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 15
Soochow University (CN), First Affiliated Hospital of Soochow University (CN)
National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, National Key Research and Development Program of China, Science and Technology Program of Suzhou
Openalex Percentile: Top 7%
Lymphoma Diagnosis and Treatment
3.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.